WST WS

WST West Pharmaceutical Services, I

Healthcare · Medical Instruments & Supplies

4 · Weak Momentum 8.0 · Strong Safe Aristocrat

328.20

-7.67%

About the company

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

0.27%
11.25%
0.88
23.1B
41.97
7.82
282.77

52-week range

328
low 224 high 386
Yield Growth Momentum Safety Value Health

Dividend deep dive

West Pharmaceutical Services, I (WST) operates in the Medical Instruments & Supplies sector. The company currently offers a dividend yield of 0.26%. This yield is within its 5-year historical range of 0.18% to 0.33%, with a 5-year average of 0.24%. Yield Theory suggests the stock is currently valued "fairly." No momentum, value, or overall rating scores are provided in the data.

Dividend history

West Pharmaceutical Services, I has maintained a 28-year dividend increase streak, earning it a "Champion" tier classification. The dividend has grown with a 3-year compound annual growth rate (CAGR) of 5.27% and a 5-year CAGR of 5.59%. At this rate, the dividend would double in approximately 12.9 years. Annual dividends per share have been: 0.40 USD (2014), 0.44 USD (2015), 0.48 USD (2016), 0.52 USD (2017), 0.56 USD (2018), 0.60 USD (2019), 0.64 USD (2020), 0.68 USD (2021), 0.72 USD (2022), 0.76 USD (2023), 0.80 USD (2024), and 0.84 USD (2025).

Quantic · Free

Unlock the full analysis

Dividend safety read, the key risks, and what to watch next.

AI-generated from Quantic's dividend data · Updated 24 Jul 2026 · Information, not financial advice.

Price history

469 340 211 2021 2022 2023 2024 2025 2026 2020-08 · 284 2020-09 · 275 2020-10 · 272 2020-11 · 275 2020-12 · 283 2021-01 · 299 2021-02 · 281 2021-03 · 282 2021-04 · 329 2021-05 · 348 2021-06 · 359 2021-07 · 412 2021-08 · 452 2021-09 · 425 2021-10 · 430 2021-11 · 443 2021-12 · 469 2022-01 · 393 2022-02 · 387 2022-03 · 411 2022-04 · 315 2022-05 · 310 2022-06 · 302 2022-07 · 344 2022-08 · 297 2022-09 · 246 2022-10 · 230 2022-11 · 235 2022-12 · 235 2023-01 · 266 2023-02 · 317 2023-03 · 346 2023-04 · 361 2023-05 · 335 2023-06 · 382 2023-07 · 368 2023-08 · 407 2023-09 · 375 2023-10 · 318 2023-11 · 351 2023-12 · 352 2024-01 · 373 2024-02 · 358 2024-03 · 396 2024-04 · 357 2024-05 · 331 2024-06 · 329 2024-07 · 306 2024-08 · 314 2024-09 · 300 2024-10 · 308 2024-11 · 326 2024-12 · 328 2025-01 · 342 2025-02 · 232 2025-03 · 224 2025-04 · 211 2025-05 · 211 2025-06 · 219 2025-07 · 239 2025-08 · 247 2025-09 · 262 2025-10 · 282 2025-11 · 277 2025-12 · 275 2026-01 · 231 2026-02 · 254 2026-03 · 251 2026-04 · 298 2026-05 · 323 2026-06 · 359 2026-07 · 334
Price

Dividend profile

Frequency
Quarterly
Growth (TTM)
+4.8%
CAGR 3y
+5.3%
+5.6%
28 years

(5-year)

Now 0.3%
0.2% avg 0.2% 0.3%

Payment calendar

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec

Dividend history

CAGR 3y +5.3% CAGR 5y +5.6% 28y streak
14 15 16 17 18 19 20 21 22 23 24 25

Per-share dividend by year

Quantic · Free

Unlock valuation & strategy

Two DDM fair values, margin of safety, sector value rank, Dividend Yield Theory, doubling time and max drawdown.

Debt & leverage

10.4%
2.82
1.79
Debt vs cash
Debt Cash
Total debt
312.1M USD
Total cash
435.8M USD
915.6M USD

Latest reported balance-sheet figures.

watched by 1

Appears in these lists

WST qualifies for these curated dividend rankings.

Information, not financial advice.

Quantic · Free

Track WST and your whole portfolio

Real yield, dividend safety, net-of-tax income and your path to freedom — free, no broker connection.

€0

The information on Quantic is provided for informational and educational purposes only. It is general in nature, does not take into account your personal financial situation, and does not constitute investment, financial, tax, or legal advice — nor a recommendation to buy or sell any security. Investing involves risk, including possible loss of principal; past performance is not a reliable indicator of future results. Market data comes from third-party providers and may be delayed or inaccurate. Before making any investment decision, consider your objectives, time horizon, risk tolerance, and diversification, and consult a qualified financial professional. Quantic is not a registered investment adviser or broker-dealer.

Built with Elixir, Phoenix LiveView, and Tailwind CSS

© 2026 Francesc Leveque